Titre : Chimiokine CCL2

Chimiokine CCL2 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Exercise Test
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Chimiokine CCL2 : Questions médicales les plus fréquentes", "headline": "Chimiokine CCL2 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Chimiokine CCL2 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-26", "dateModified": "2025-02-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Chimiokine CCL2" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines chimioattractives monocytaires", "url": "https://questionsmedicales.fr/mesh/D018945", "about": { "@type": "MedicalCondition", "name": "Protéines chimioattractives monocytaires", "code": { "@type": "MedicalCode", "code": "D018945", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.374.200.110.990" } } }, "about": { "@type": "MedicalCondition", "name": "Chimiokine CCL2", "alternateName": "Chemokine CCL2", "code": { "@type": "MedicalCode", "code": "D018932", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nidhi Joshi", "url": "https://questionsmedicales.fr/author/Nidhi%20Joshi", "affiliation": { "@type": "Organization", "name": "Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India." } }, { "@type": "Person", "name": "Krishna Mohan Poluri", "url": "https://questionsmedicales.fr/author/Krishna%20Mohan%20Poluri", "affiliation": { "@type": "Organization", "name": "Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India. Electronic address: krishfbt@iitr.ac.in." } }, { "@type": "Person", "name": "Nupur Nagar", "url": "https://questionsmedicales.fr/author/Nupur%20Nagar", "affiliation": { "@type": "Organization", "name": "Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India." } }, { "@type": "Person", "name": "Élora Midavaine", "url": "https://questionsmedicales.fr/author/%C3%89lora%20Midavaine", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de pharmacologie de Sherbrooke, Université de Sherbrooke, 3001, 12e Avenue Nord, Sherbrooke, QC, Canada. elora.midavaine@usherbrooke.ca." } }, { "@type": "Person", "name": "Philippe Sarret", "url": "https://questionsmedicales.fr/author/Philippe%20Sarret", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de pharmacologie de Sherbrooke, Université de Sherbrooke, 3001, 12e Avenue Nord, Sherbrooke, QC, Canada." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Impact of face masks during the treadmill exercise tests.", "datePublished": "2022-06-24", "url": "https://questionsmedicales.fr/article/35760609", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.medcli.2022.05.006" } }, { "@type": "ScholarlyArticle", "name": "Combined Neurocognitive and Exercise Tolerance Testing Improves Objectivity of Buffalo Concussion Treadmill Test.", "datePublished": "2023-03-20", "url": "https://questionsmedicales.fr/article/36940684", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1123/jsr.2022-0354" } }, { "@type": "ScholarlyArticle", "name": "Do Clinical Exercise Tests Permit Exercise Threshold Identification in Patients Referred to Cardiac Rehabilitation?", "datePublished": "2023-07-28", "url": "https://questionsmedicales.fr/article/37517474", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cjca.2023.07.029" } }, { "@type": "ScholarlyArticle", "name": "Practical Management: A Standardized Aerobic Exercise Program for Adolescents With Concussion in the Absence of Graded Exercise Testing.", "datePublished": "2022-12-27", "url": "https://questionsmedicales.fr/article/36728783", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/JSM.0000000000001116" } }, { "@type": "ScholarlyArticle", "name": "Exercise-induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test-echocardiographic study.", "datePublished": "2022-06-28", "url": "https://questionsmedicales.fr/article/36434342", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10554-022-02671-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Protéines et peptides de signalisation intercellulaire", "item": "https://questionsmedicales.fr/mesh/D036341" }, { "@type": "ListItem", "position": 4, "name": "Cytokines", "item": "https://questionsmedicales.fr/mesh/D016207" }, { "@type": "ListItem", "position": 5, "name": "Chimiokines", "item": "https://questionsmedicales.fr/mesh/D018925" }, { "@type": "ListItem", "position": 6, "name": "Chimiokines CC", "item": "https://questionsmedicales.fr/mesh/D019742" }, { "@type": "ListItem", "position": 7, "name": "Protéines chimioattractives monocytaires", "item": "https://questionsmedicales.fr/mesh/D018945" }, { "@type": "ListItem", "position": 8, "name": "Chimiokine CCL2", "item": "https://questionsmedicales.fr/mesh/D018932" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Chimiokine CCL2 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Chimiokine CCL2", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Chimiokine CCL2", "description": "Comment mesurer les niveaux de CCL2 ?\nQuels tests sont utilisés pour évaluer l'inflammation ?\nCCL2 est-il un biomarqueur de maladies ?\nComment CCL2 est-il lié à la maladie cardiovasculaire ?\nPeut-on détecter CCL2 dans le liquide céphalorachidien ?", "url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Exercise+Test&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Chimiokine CCL2", "description": "Quels symptômes sont associés à des niveaux élevés de CCL2 ?\nCCL2 est-il lié à des symptômes neurologiques ?\nComment CCL2 affecte-t-il le système immunitaire ?\nDes niveaux de CCL2 peuvent-ils causer de la douleur ?\nCCL2 est-il impliqué dans des maladies respiratoires ?", "url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Exercise+Test&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Chimiokine CCL2", "description": "Comment réduire les niveaux de CCL2 ?\nLe stress influence-t-il CCL2 ?\nY a-t-il des aliments qui réduisent CCL2 ?\nL'exercice physique affecte-t-il CCL2 ?\nLa qualité du sommeil influence-t-elle CCL2 ?", "url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Exercise+Test&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Chimiokine CCL2", "description": "Quels traitements ciblent CCL2 ?\nCCL2 peut-il être une cible pour des thérapies anticancéreuses ?\nComment les anti-inflammatoires affectent-ils CCL2 ?\nY a-t-il des traitements naturels pour CCL2 ?\nLes corticostéroïdes influencent-ils CCL2 ?", "url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Exercise+Test&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Chimiokine CCL2", "description": "Quelles complications sont liées à CCL2 ?\nCCL2 est-il impliqué dans des maladies neurodégénératives ?\nComment CCL2 affecte-t-il le diabète ?\nY a-t-il des risques d'infection liés à CCL2 ?\nCCL2 est-il lié à des troubles auto-immuns ?", "url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Exercise+Test&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Chimiokine CCL2", "description": "Quels facteurs augmentent CCL2 ?\nL'âge influence-t-il les niveaux de CCL2 ?\nLes infections chroniques affectent-elles CCL2 ?\nLe régime alimentaire influence-t-il CCL2 ?\nLe manque d'exercice est-il un facteur de risque pour CCL2 ?", "url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Exercise+Test&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment mesurer les niveaux de CCL2 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de CCL2 peuvent être mesurés par des tests ELISA dans le sérum ou les tissus." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'inflammation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme la CRP et la mesure de CCL2 aident à évaluer l'inflammation." } }, { "@type": "Question", "name": "CCL2 est-il un biomarqueur de maladies ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, CCL2 est un biomarqueur potentiel pour des maladies inflammatoires et auto-immunes." } }, { "@type": "Question", "name": "Comment CCL2 est-il lié à la maladie cardiovasculaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de CCL2 sont associés à l'inflammation dans les maladies cardiovasculaires." } }, { "@type": "Question", "name": "Peut-on détecter CCL2 dans le liquide céphalorachidien ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, CCL2 peut être détecté dans le liquide céphalorachidien, indiquant une inflammation neurologique." } }, { "@type": "Question", "name": "Quels symptômes sont associés à des niveaux élevés de CCL2 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de CCL2 peuvent entraîner des symptômes d'inflammation comme douleur et fatigue." } }, { "@type": "Question", "name": "CCL2 est-il lié à des symptômes neurologiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, CCL2 est impliqué dans des symptômes neurologiques dans des maladies comme la sclérose en plaques." } }, { "@type": "Question", "name": "Comment CCL2 affecte-t-il le système immunitaire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "CCL2 attire les monocytes et les lymphocytes, influençant la réponse immunitaire." } }, { "@type": "Question", "name": "Des niveaux de CCL2 peuvent-ils causer de la douleur ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, CCL2 peut contribuer à la douleur en favorisant l'inflammation dans les tissus." } }, { "@type": "Question", "name": "CCL2 est-il impliqué dans des maladies respiratoires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, CCL2 est associé à des maladies respiratoires comme l'asthme et la BPCO." } }, { "@type": "Question", "name": "Comment réduire les niveaux de CCL2 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Adopter un mode de vie sain, avec une alimentation équilibrée et de l'exercice, peut aider." } }, { "@type": "Question", "name": "Le stress influence-t-il CCL2 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut augmenter les niveaux de CCL2 et l'inflammation." } }, { "@type": "Question", "name": "Y a-t-il des aliments qui réduisent CCL2 ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des aliments riches en antioxydants, comme les baies, peuvent aider à réduire CCL2." } }, { "@type": "Question", "name": "L'exercice physique affecte-t-il CCL2 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut diminuer les niveaux de CCL2 et améliorer la santé globale." } }, { "@type": "Question", "name": "La qualité du sommeil influence-t-elle CCL2 ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un sommeil de qualité peut réduire l'inflammation et les niveaux de CCL2 dans le corps." } }, { "@type": "Question", "name": "Quels traitements ciblent CCL2 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs de CCL2 sont en développement pour traiter des maladies inflammatoires." } }, { "@type": "Question", "name": "CCL2 peut-il être une cible pour des thérapies anticancéreuses ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, cibler CCL2 pourrait aider à réduire l'infiltration tumorale et l'inflammation." } }, { "@type": "Question", "name": "Comment les anti-inflammatoires affectent-ils CCL2 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les anti-inflammatoires peuvent réduire les niveaux de CCL2 et atténuer l'inflammation." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour CCL2 ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certaines plantes médicinales peuvent moduler les niveaux de CCL2, mais des études sont nécessaires." } }, { "@type": "Question", "name": "Les corticostéroïdes influencent-ils CCL2 ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les corticostéroïdes peuvent réduire l'expression de CCL2 dans les tissus inflammés." } }, { "@type": "Question", "name": "Quelles complications sont liées à CCL2 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de CCL2 peuvent entraîner des complications dans les maladies cardiovasculaires." } }, { "@type": "Question", "name": "CCL2 est-il impliqué dans des maladies neurodégénératives ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, CCL2 est associé à des complications dans des maladies comme Alzheimer et Parkinson." } }, { "@type": "Question", "name": "Comment CCL2 affecte-t-il le diabète ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "CCL2 peut contribuer à l'inflammation et aux complications associées au diabète." } }, { "@type": "Question", "name": "Y a-t-il des risques d'infection liés à CCL2 ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de CCL2 peuvent augmenter le risque d'infections en favorisant l'inflammation." } }, { "@type": "Question", "name": "CCL2 est-il lié à des troubles auto-immuns ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, CCL2 est impliqué dans des complications de troubles auto-immuns comme la polyarthrite." } }, { "@type": "Question", "name": "Quels facteurs augmentent CCL2 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'obésité et le stress sont des facteurs de risque augmentant CCL2." } }, { "@type": "Question", "name": "L'âge influence-t-il les niveaux de CCL2 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux de CCL2 tendent à augmenter avec l'âge, contribuant à l'inflammation." } }, { "@type": "Question", "name": "Les infections chroniques affectent-elles CCL2 ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections chroniques peuvent augmenter les niveaux de CCL2 dans le corps." } }, { "@type": "Question", "name": "Le régime alimentaire influence-t-il CCL2 ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un régime riche en graisses saturées peut augmenter les niveaux de CCL2 et l'inflammation." } }, { "@type": "Question", "name": "Le manque d'exercice est-il un facteur de risque pour CCL2 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le manque d'exercice peut contribuer à des niveaux élevés de CCL2 et à l'inflammation." } } ] } ] }

Sources (10000 au total)

Impact of face masks during the treadmill exercise tests.

There is little literature on the use of face masks in a treadmill test (TMT) during the COVID-19 pandemic. The objective of this study is to analyze the impact of face masks during a TMT performed du... Retrospective observational unicentric study of patients undergoing TMT. The inclusion criterion were being over 16years old and having performed at least one TMT in the prepandemic and postpandemic p... One thousand six hundred fifty-five patients were included in the study. Nine hundred thirty-five (56.5%) were men and 720 (43.5%) women. The mean age was 57.3±14.9 and the mean follow-up time was 15.... The use of surgical or FFP2 face masks during the TMT did not affect functional capacity, blood pressure, heart rate, or increased ventricular arrhythmias....

Combined Neurocognitive and Exercise Tolerance Testing Improves Objectivity of Buffalo Concussion Treadmill Test.

The Buffalo Concussion Treadmill Test (BCTT) is a standard assessment of exercise tolerance utilized for exercise prescription following concussion and to inform decisions regarding return to play. On... Prospective cohort study, pretest/posttest.... A total of 30 participants included 13 women (43.3%), age 23.4 (1.93) years, height 173.56 (10) cm, weight 77.35 (16.3) kg, and 11 (36.7%) with history of concussion. All participants completed a neur... BCTT: Average percentage of heart rate maximum (%HRmax) = 93.97% (4.8%); average maximum rating of perceived exertion = 18.6 (1.5). Time-based performance in single-task and dual-task conditions signi... Healthy participants demonstrated improvements across multiple domains of neurocognitive performance following the exercise tolerance testing on the BCTT. Understanding normal responses in neurocognit...

Do Clinical Exercise Tests Permit Exercise Threshold Identification in Patients Referred to Cardiac Rehabilitation?

To evaluate the feasibility of "threshold-based" aerobic exercise prescription in cardiovascular disease, we aimed to quantify the proportion of patients whose clinical cardiopulmonary exercise test (... Breath-by-breath CPET data of 1102 patients (65 ± 12 years) referred to cardiac rehabilitation were analyzed to identify peak O... Mean V˙O... Only 32% of CPETs exhibited both θ...

Exercise-induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test-echocardiographic study.

Pulmonary arterial hypertension (PAH), documented in a significant portion of hypertrophic cardiomyopathy (HCM) patients, has been shown to adversely impact prognosis. In most HCM patients congestive ...

Complexity and pitfalls in maximal exercise testing for persons with multiple sclerosis.

Valid measurements of cardiorespiratory fitness in persons with multiple sclerosis (pwMS) are essential during inpatient rehabilitation for a precise evaluation of the current health status, for defin... This cross-sectional study comprises a retrospective examination of ACSM criteria for maximal effort during graded CPET of n = 380 inpatient pwMS (mean age = 48 ± 11 years, 66% female). Chi-squared or... Only 60% of the overall sample attained a respiratory exchange ratio ≥ 1.10. With regard to the definition applied, only 24% or 40% of the participants achieved an oxygen consumption plateau, and 17% ... Our findings suggest that a relevant proportion of inpatient pwMS do not attain common criteria utilized to verify maximal oxygen consumption. Identified predictors for criteria attainment can be used...

The feasibility and safety of stepwise protocol in cardiopulmonary exercise testing-exercise stress echocardiography for subjects with heart failure.

Exercise stress testing using a ramp protocol has been favored for cardiopulmonary exercise testing (CPX) in patients with heart failure (HF). However, the stepwise protocol for CPX was preferred for ... Ambulatory outpatients with chronic HF were enrolled for a symptom-limited stepwise bicycle exercise test in the semi-supine position on a cycle ergometer. The test was started at a workload of 30 W a... Among a total of 36 participants (age 61.2 ± 12.4 years; 69.4% men), all subjects achieved anerobic threshold during CPX-ESE and reached 72.3% of the age-predicted peak heart rate. The peak oxygen con... The stepwise protocol, with an initial workload of 30 W, followed by 15 W increments every 3 minutes, was feasible and provided an adequate stress load for patients with HF. This exercise stress modal...

Recumbent Ergometer vs Treadmill Cardiopulmonary Exercise Test in HFpEF: Implications for Chronotropic Response and Exercise Capacity.

Cardiopulmonary exercise testing (CPET) can identify mechanisms of exercise intolerance in heart failure with preserved ejection fraction (HFpEF), but exercise modalities with differing body positions... Subjects with stable HFpEF (n = 23) underwent noninvasive treadmill CPET, followed by an invasive recumbent-cycle ergometer CPET within 3 months. A comparison group undergoing similar studies included... The peak oxygen consumption (VO... Compared to recumbent ergometer, treadmill CPET revealed higher VO...